Top Markets
#1 Black Phoenix Black Phoenix +355.27%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.70%
#4 OpenEden OpenEden +56.84%
#5 Akedo Akedo +56.63%
#6 BasedHype BasedHype +27.37%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +20.66%
#9 Acurast Acurast +19.36%
#10 Humanity Humanity +17.61%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Synairgen plc Synairgen plc

Synairgen plc

SNG
Rang in Aktien #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Aktienkurs
$0.01292666
Zuletzt synchronisiert: 2025-04-08
Marktkapitalisierung
$157.54K
Veränderung (1 Tag)
6.84%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Synairgen plc (SNG)

Kategorie

Healthcare
Aktien-Split-Historie für Synairgen plc (SNG)
Die Aktie Synairgen plc (Symbol: SNG) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 13, 2026 statt.
Eine SNG-Aktie, die vor dem Aug 13, 2026 gekauft wurde, entspricht heute 0 SNG-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE